Moreover, lestaurtinib, a janus kinase and fms-like tyrosine kinase 3 (FLT3) inhibitor, was shown to attenuate acute lung injury by reducing neutrophil infiltration, which may also attenuate brain edema by inhibiting the JAK2/STAT3 pathway (Li et al., 2019). Here, FLT3 is linked to injury.